News8 months ago
Cellectis to present Q1 2024 financial results on May 28, 2024
Cellectis Inc. NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene...
